Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Clinical trial NCT06176716 · UNKNOWN

Trial details

NCT number: NCT06176716
Sponsor: Ahon Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2023-12-06
Primary completion: 2024-03-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.